NTNHA-Based BoNT Purification and Activation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing and purifying botulinum neurotoxins (BoNTs) are inefficient, labor-intensive, and compromise the final yield and biological activity due to harsh conditions and the need for additional purification steps, especially with recombinant forms which often require affinity tags that affect activity and require removal.
Innovation Solution
A method involving a non-toxic non-hemagglutinin (NTNHA) polypeptide covalently linked to a heterologous affinity moiety, allowing for pH-dependent binding and purification of BoNTs, enabling efficient affinity purification and activation while minimizing non-specific degradation and antigenicity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If affinity tags (e.g., His-6, GST) are fused to BoNTs to facilitate purification, then purification efficiency is improved, but biological activity is compromised and antigenicity increases
Solution Approach 1:
The invention extracts and utilizes the natural affinity interaction between BoNT and NTNHA, separating this specific binding capability from the toxic components. By isolating NTNHA as a standalone purification agent, the method achieves efficient purification without requiring fusion tags that compromise toxin activity or introduce antigenicity.
Solution Approach 2:
NTNHA serves as an intermediary molecule that mediates the purification process. It binds specifically to BoNT through natural affinity interactions, enabling selective purification while leaving the toxin's biological activity intact. The NTNHA-BoNT complex can be formed and purified, then the toxin released, providing a tag-free purification approach.
2Manufacturing precision
If multiple chromatography steps are used for purification, then purity is improved, but process complexity and time consumption increase
Solution Approach 1:
The invention performs preliminary action by utilizing the natural affinity between NTNHA and BoNT to achieve selective binding in the first purification step. This pre-established specific interaction allows subsequent steps to focus on removing different types of contaminants, reducing the total number of chromatography steps required while maintaining high purity.
Solution Approach 2:
The method employs parameter changes by adjusting pH conditions to control the binding and release of BoNT from NTNHA. By optimizing pH gradients across different purification steps, the process achieves high purity through selective elution without requiring excessive chromatography steps, simplifying the overall workflow.
3Reliability
If activation endoproteinase is added for toxin activation, then biological activity is improved, but non-specific degradation increases and additional purification steps are required
Solution Approach 1:
The NTNHA-BoNT complex serves as a protective intermediary structure during activation. The complex formation shields the toxin from non-specific proteolytic degradation while allowing controlled activation. This mediator approach enables safe activation without excessive degradation, reducing the need for additional purification steps to remove degradation products.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method facilitates high-yield, high-purity purification and activation of BoNTs under mild conditions, reducing the need for additional purification steps and protecting the toxin from non-specific proteolysis, thereby preserving biological activity.
Implementation Method 1
allowing for pH-dependent binding and purification of BoNTs
Implementation Method 2
A method involving a non-toxic non-hemagglutinin (NTNHA) polypeptide covalently linked to a heterologous affinity moiety, allowing for pH-dependent binding and purification of BoNTs
Data Source
AI summary
Disclosed herein are methods for the isolation and purification of a botulinum neurotoxin (BoNT) protein, or a polypeptide comprising a receptor binding domain of BoNT, from a solution. The method comprises contacting the solution containing the protein or polypeptide to a matrix which has attached thereto a non-toxic non-hemagglutinin (NTNHA) under conditions appropriate for binding, washing the matrix to thereby remove unbound materials, and eluting the protein or polypeptide with a solution that dissociates the bound protein from the NTNHA. Conditions appropriate for binding are a pH of less than 7.5 (e.g, 6). Conditions appropriate for dissociation are a pH greater than or equal to 7.5 (e.g., 8). Compositions specific to the methods are also disclosed.